Clinical Trial Update: Dexamethasone in Preventing Hearing Loss in Patients Receiving Cisplatin [NA]

View source ↗

Summary

A clinical trial evaluating dexamethasone to prevent cisplatin-induced hearing loss in cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Aaron Moberly | Conditions: Malignant Neoplasm, Ototoxicity | NA | Status: WITHDRAWN